您的位置:首页 > 会议日程
John Gribben
分享到:
Centre for Haemato-Oncology, Barts Cancer Institute, St. Bartholomews Hospital, Queen Mary, University of London, United Kingdom | 血液内科

MD DSc FRCP FRCPath FMed Sci

Professor of Medical Oncology



European Hematology Association (EHA), President 2019-2021

President-elect 2017-2109

EHA Governing Board, 2015-

International workshop for NHL – Chair 2014-

MRC Molecular and Cellular Medicine Board (MCMB), 2007-2012



KEY REBULICATIONS 主要发表:

Expression of FOXP3, CD68 and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma is Predictive of outcome. J Clin Oncol (2013) 31(2):256-62. PMID: 23045593

E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction. Proc Natl Acad Sci USA (2009) 106(15):6250-5. PMID: 19332800

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest (2008) 118(7):2427-37. PMID: 18551193

SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL. Blood (2008) 112(2):394-7. PMID: 18434611


讲座视频:0

论文摘要:2

1277

0

0

日期 时间 会场 Session 角色 讲题
2020-09-26 08:00-08:30 主会场/大宴会厅

CSH-EHA论坛

讲者 Targeting the tumor microenvironment in lymphoma.